Loading...
Tsuruha Holdings Inc.
TSUSF•PNK
Healthcare
Medical - Pharmaceuticals
$55.00
$0.00(0.00%)
Tsuruha Holdings Inc. (TSUSF) Financial Performance & Income Statement Overview
Review Tsuruha Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.30%
↑ 4.30%
Operating Income Growth
-2.39%
↓ 2.39%
Net Income Growth
-9.53%
↓ 9.53%
Operating Cash Flow Growth
24.40%
↑ 24.40%
Operating Margin
4.73%
↑ 4.73%
Gross Margin
30.31%
↑ 30.31%
Net Profit Margin
2.17%
↑ 2.17%
ROE
5.98%
↑ 5.98%
ROIC
10.06%
↑ 10.06%
Tsuruha Holdings Inc. (TSUSF) Income Statement & Financial Overview
Review Tsuruha Holdings Inc.'s (TSUSF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $263.12B | $273.41B | $238.64B | $247.33B |
| Cost of Revenue | $182.80B | $190.96B | $165.99B | $171.96B |
| Gross Profit | $80.31B | $82.45B | $72.65B | $75.37B |
| Gross Profit Ratio | $0.31 | $0.30 | $0.30 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $68.83B | $67.34B | $64.80B | $62.35B |
| Operating Expenses | $68.83B | $67.34B | $64.79B | $62.35B |
| Total Costs & Expenses | $251.63B | $258.30B | $230.79B | $234.31B |
| Interest Income | $26.00M | $0.00 | $31.00M | $30.00M |
| Interest Expense | $422.00M | $0.00 | $478.00M | $277.00M |
| Depreciation & Amortization | $4.80B | $4.50B | $43812.00 | -$39586.00 |
| EBITDA | $4.53B | $19.61B | $8.09B | $13.01B |
| EBITDA Ratio | $0.02 | $0.07 | $0.03 | $0.05 |
| Operating Income | $11.48B | $15.11B | $7.85B | $13.02B |
| Operating Income Ratio | $0.04 | $0.06 | $0.03 | $0.05 |
| Other Income/Expenses (Net) | -$12.18B | -$134.00M | -$2.59B | -$286.00M |
| Income Before Tax | -$693.00M | $14.97B | $5.26B | $12.73B |
| Income Before Tax Ratio | -$0.003 | $0.05 | $0.02 | $0.05 |
| Income Tax Expense | $153.00M | $5.27B | $1.33B | $4.59B |
| Net Income | -$803.00M | $8.97B | $3.55B | $7.08B |
| Net Income Ratio | -$0.003 | $0.03 | $0.01 | $0.03 |
| EPS | -$16.50 | $184.51 | $72.94 | $145.69 |
| Diluted EPS | -$16.50 | $183.97 | $72.42 | $145.69 |
| Weighted Avg Shares Outstanding | $48.67M | $48.64M | $48.60M | $48.60M |
| Weighted Avg Shares Outstanding (Diluted) | $48.67M | $48.78M | $48.83M | $48.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan